February 1–2, 2027 | Novotel Al Barsha, Dubai, UAE

Head and neck cancer remains one of the most complex and challenging areas in oncology, encompassing a diverse group of malignancies that arise in the oral cavity, pharynx, larynx, nasal cavity, paranasal sinuses, salivary glands, and related anatomical structures. Advances in molecular diagnostics, immunotherapy, precision medicine, minimally invasive surgery, and multidisciplinary care have significantly improved patient outcomes while enhancing quality of life.

The 13th International Cancer and Medical Oncology Conference and Exhibition provides a premier global platform for clinicians, oncologists, surgeons, researchers, academicians, healthcare professionals, and industry leaders to discuss the latest breakthroughs in head and neck cancer research, diagnosis, treatment, and patient management.

About Track 21: Head and Neck Cancer

Track 21 focuses on the latest developments in understanding, diagnosing, and treating head and neck cancers. The sessions will highlight emerging research, innovative therapeutic approaches, advancements in surgical techniques, radiation oncology, targeted therapies, and immunotherapeutic strategies.

Participants will gain valuable insights into:

Epidemiology and risk factors
HPV-associated head and neck cancers
Oral and oropharyngeal cancers
Laryngeal and hypopharyngeal cancers
Salivary gland tumors
Nasopharyngeal carcinoma
Molecular biomarkers and precision oncology
Immunotherapy and checkpoint inhibitors
Radiation therapy advancements
Reconstructive and robotic surgery
Survivorship and quality of life
Multidisciplinary patient care
Early detection and prevention strategies
Clinical trials and emerging therapies

Why Head and Neck Cancer Research Matters

Head and neck cancers account for a substantial global cancer burden, with many cases diagnosed at advanced stages. Tobacco use, alcohol consumption, viral infections such as HPV and Epstein-Barr virus, environmental exposures, and genetic factors contribute significantly to disease incidence.

Recent innovations in oncology have transformed the treatment landscape by introducing:

Precision medicine approaches
Biomarker-driven therapies
Artificial intelligence-assisted diagnostics
Immunotherapy combinations
Organ-preservation strategies
Enhanced rehabilitation and supportive care

The conference aims to bridge the gap between laboratory discoveries and clinical applications, fostering collaborations that accelerate improvements in patient outcomes.

Key Benefits of Attending Track 21

Scientific Knowledge Enhancement

Gain access to the latest evidence-based research and clinical developments in head and neck oncology.

Networking Opportunities

Connect with leading oncologists, surgeons, researchers, pharmaceutical experts, and healthcare professionals from across the globe.

Exposure to Emerging Technologies

Explore cutting-edge technologies, novel therapeutics, and innovative diagnostic tools shaping future cancer care.

Clinical Practice Advancement

Learn practical approaches that can be integrated into daily oncology practice and multidisciplinary treatment planning.

Research Collaboration

Identify opportunities for collaborative research projects, publications, grants, and international partnerships.

Professional Development

Enhance academic and professional credentials through participation in high-level scientific discussions and presentations.

Conference Highlights

The conference will feature:

Attendees will have opportunities to present their latest research findings and engage directly with experts from academia, healthcare institutions, research organizations, and industry.

About the Conference Venue

Novotel Al Barsha Dubai serves as the official venue for the conference

Located in the vibrant city of Dubai, the venue offers modern conference facilities, advanced meeting spaces, excellent transportation connectivity, and convenient access to major attractions, shopping destinations, and business districts.

Dubai is recognized as a global hub for innovation, healthcare, business, and international collaboration, making it an ideal destination for a world-class oncology conference.

CME and CPD Accreditation

The conference is expected to provide approximately 30 CME/CPD Credits, subject to accreditation approval and applicable professional guidelines.

Benefits of CME/CPD participation include:

Maintenance of professional competency
Continuing medical education requirements
Clinical skill enhancement
Evidence-based practice updates
Career advancement opportunities
International recognition of professional development activities
Improved patient care outcomes

Healthcare professionals can leverage these educational credits to support their ongoing certification and professional growth objectives.

Who Should Attend?

Conference Summary

Track 21: Head and Neck Cancer offers a comprehensive scientific program dedicated to addressing the current challenges and future opportunities in head and neck oncology. Through expert-led sessions, cutting-edge research presentations, and multidisciplinary discussions, participants will gain valuable insights into improving diagnosis, treatment, and survivorship outcomes for patients worldwide.

The conference serves as a unique platform to exchange knowledge, foster collaborations, and advance innovations that can shape the future of cancer care.

Conclusion

Head and neck cancer continues to pose significant clinical and public health challenges globally. Advances in precision medicine, immunotherapy, molecular diagnostics, and multidisciplinary treatment approaches are transforming patient care and improving survival outcomes.

The 13th International Cancer and Medical Oncology Conference and Exhibition provides an exceptional opportunity for healthcare professionals, researchers, and industry leaders to explore the latest scientific developments, establish meaningful collaborations, and contribute to the advancement of oncology research and clinical practice.

Participation in Track 21 will empower attendees with valuable knowledge, professional connections, and practical insights that can directly impact patient care and future research endeavors.